Deliver Consulting Limited | Back to main site


  • 张延延




    Dr. Yan-Yan Zhang is currently Director, ClinPharm Asia-Pacific Group Leader at Beigene, where he develops and oversees the execution of clinical pharmacology/pharmacometrics strategies for company portfolio, including small molecules and biologics, with a scope from candidate selection through post-marketing deliverables. Dr. Zhang received his Ph.D. from Dalian Institute of Chemical Physics, Chinese Academy of Sciences in 2009. He continued at this institute as Assistant Professor, and then spent another two years in University of Illinois at Chicago as Postdoc. From 2013―2017, he was Senior Scientist and Associate Fellow at GlaxoSmithKline R&D. Before he joined Beigene, he has also served as Associate Director, PKDM at Sanofi R&D for four years. His research interests mainly focus on first time in human dose selection, Physiologically-Based Pharmacokinetic (PBPK), mechanistic PK-PD modeling, and in silico prediction of PK properties using machine learning technologies. He has published 45 peer-reviewed scientific papers, contributed with 14 patents, and served as reviewers for a number of international journals.